
Trastuzumab Emtansine 100 mg Injection is a targeted anticancer therapy used to treat HER2-positive breast cancer. It combines trastuzumab with a chemotherapy agent to deliver treatment directly to cancer cells, helping to reduce damage to healthy cells.
| Manufacturer | Zydus |
| Generic Name | Trastuzumab Emtansine |
| Strength | 100mg |
| Used For | HER2-positive breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Vial | $450 | £333 | A$627 | ₱28,211 | د.ت1,309.95 | ₩602,595 | lei 2,037 | HK$3,529 | RM1,831 | ฿14,859 | S$570 | د.إ1,652.85 | ر.س1,689.75 | ر.ق1,638.45 | د.ك137.250 |
Trastuzumab emtansine is an antibody-drug conjugate. Trastuzumab targets the HER2 receptor on cancer cells, and it carries a chemotherapy drug (emtansine) directly into the cancer cell. This targeted delivery kills cancer cells while limiting damage to normal cells.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.